Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
Critical Reviews™ in Eukaryotic Gene Expression
Импакт фактор: 1.841 5-летний Импакт фактор: 1.927 SJR: 0.627 SNIP: 0.516 CiteScore™: 1.96

ISSN Печать: 1045-4403
ISSN Онлайн: 2162-6502

Выпуски:
Том 29, 2019 Том 28, 2018 Том 27, 2017 Том 26, 2016 Том 25, 2015 Том 24, 2014 Том 23, 2013 Том 22, 2012 Том 21, 2011 Том 20, 2010 Том 19, 2009 Том 18, 2008 Том 17, 2007 Том 16, 2006 Том 15, 2005 Том 14, 2004 Том 13, 2003 Том 12, 2002 Том 11, 2001 Том 10, 2000 Том 9, 1999 Том 8, 1998 Том 7, 1997 Том 6, 1996 Том 5, 1995 Том 4, 1994

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.2013006917
pages 103-113

Combined Gene Expression and DNA Occupancy Profiling as a Strategy to Identify Therapeutic Target(s) in t(8;21) Acute Myeloid Leukemia

Miao-Chia Lo
Moores Cancer Center, University of California San Diego, La Jolla, California
Luke F. Peterson
Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan

Краткое описание

Microarray technology has contributed valuable information to gene expression signatures of leukemia and other types of cancers and helped to identify biological markers and potential therapeutic targets for treating these diseases. Acute myeloid leukemia (AML) is often caused by aberrant fusion transcription factors resulting from chromosomal translocations, and the dysregulated genes detected by microarray include both direct and indirect targets of the oncogenic transcription factors. The ChIP-chip technology enables the identification of direct targets of a transcription factor based on its promoter occupancy and cellular context. Using AML1-ETO9a-induced AML as a cancer model and using a combined gene expression and promoter occupancy profiling approach, we recently identified CD45 as a direct down-regulated target of t(8;21) fusion proteins. This finding subsequently led us to discover the enhanced Janus activated kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway, which is negatively regulated by CD45, in t(8;21) AML. This review summarizes the background of t(8;21) leukemia, structural features of the translocation fusion proteins, and the merits of combining gene discovery technologies for the identification of therapeutic targets in t(8;21) leukemia.


Articles with similar content:

Nuclear Phospholipase C in Biological Control and Cancer
Critical Reviews™ in Eukaryotic Gene Expression, Vol.21, 2011, issue 3
Milena Fini, Irene Faenza, Lucio Cocco, Manuela Piazzi, Roberto Giardino, Giulia Ramazzotti, Matilde Y. Follo, Roberta Fiume
Protein Kinase C Control of Gene Expression
Critical Reviews™ in Eukaryotic Gene Expression, Vol.11, 2001, issue 1-3
Carlo Ventura, Margherita Maioli
Implication of Cyclin D1 in Malignant Lymphoma
Critical Reviews™ in Oncogenesis, Vol.7, 1996, issue 3-4
Ruth Rimokh, Dominique Leroux, Mary Callanan, Jean-Pierre Magaud
Combinatorial Transcriptional Regulation: The Interaction of Transcription Factors and Cell Signaling Molecules with Homeodomain Proteins in Drosophila Development
Critical Reviews™ in Eukaryotic Gene Expression, Vol.11, 2001, issue 1-3
Sarah E. Bondos, Xin-Xing Tan
Yin Yang 1 (YY1): Regulation of Survivin and Its Role In Invasion and Metastasis
Critical Reviews™ in Oncogenesis, Vol.22, 2017, issue 1-2
Nicholas R. Galloway, Kathryn F. Ball, Nathan R. Wall, TessaRae Stiff